Advertisement Pharmaceutical Business review - Page 222 of 5295 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 21, 2026

Sanofi and ScionxBio partner on mRNA therapies

Sanofi has signed a global licensing and strategic collaboration agreement with UK-based biotechnology company ScionxBio to develop long-acting messenger ribonucleic acid (mRNA) therapies using the TERA platform.

Continue
The agreement combines the work of Sanofi’s mRNA Center of Excellence with ScionxBio’s computational platform. Credit: Formatoriginal / Shutterstock.com.
October 21, 2026

FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease

Sjögren’s disease damages moisture-producing glands, causing dry mouth. Credit: Saiful52 / Shutterstock.com.
October 19, 2026

FDA approves Viatris’ Ryzumvi for adult presbyopia

Presbyopia involves the progressive loss of near-focusing capacity brought on by ageing. Credit: Vitalii Vodolazskyi/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Estuary secures $103m to advance kidney disease gene therapies
  2. Acta Pharmaceuticals raises $24m for Alzheimer’s therapies
  3. Transcripta Bio, Mayo Clinic join force on ALS therapies
  4. QCi and INmune Bio partner to study XPro in Alzheimer’s
  5. Alentis and PinotBio partner to develop claudin-1 oncology ADCs

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography